During the past decade, Alpine Clinical Research Center conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 27 clinical trials were completed, i.e. on average, 108% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 17 clinical trials were completed. i.e. 170% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alpine Clinical Research Center" #1 sponsor was "Pfizer" with 9 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Allergan" with 4 trials sponsored, "BioCryst Pharmaceuticals" with 3 trials sponsored and "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alpine Clinical Research Center" #1 collaborator was "Pfizer" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Alpine Clinical Research Center" are "Alzheimer's Disease" (7 trials), "Alzheimer Disease" (4 trials), "Idiopathic Hypersomnia" (4 trials), "Attention Deficit Hyperactivity Disorder" (3 trials) and "Low Back Pain" (3 trials). Many other conditions were trialed in "Alpine Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Alpine Clinical Research Center" are "Drug" (49 trials), "Biological" (6 trials), "Other" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "placebo" (4 trials), "Bapineuzumab 0.5 mg/kg" (3 trials), "Bapineuzumab 1.0 m/kg" (2 trials) and "FT218" (2 trials). Other intervention names were less common.

The vast majority of trials in "Alpine Clinical Research Center" are 54 trials for "All" genders.

Currently, there are NaN active trials in "Alpine Clinical Research Center". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 38 completed trials in Alpine Clinical Research Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Alpine Clinical Research Center, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".